Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy

Randomized Study Evaluating Cost of Arthrex Nano Arthroscopy Products in Arthroscopic Knee ACL Surgery Versus Conventional Arthroscopy

The study is a pilot study designed to generate preliminary data regarding the cost of ACL surgery using NanoScope versus conventional arthroscopy in a traditional operating room (OR) setting.

Inclusion Criteria:

• Subject is 18 - 60 years of age.
• Subject body mass index (BMI) is 40 or lower (BMI ≤ 40).
• Subject signed informed consent and is willing and able to comply with all study requirements and follow-up visits.
• Confirmed ACL injury by MRI and physical exam as per standard of care.
• Subjects not excluded for having meniscal pathology that requires resection or repair.
• Subjects not excluded for having lateral-extra-articular tenodesis

Exclusion Criteria:

• Revision ACL case.
• Current bilateral knee injury.
• Insufficient quantity or quality of bone.
• Blood supply limitations and previous infections which may retard healing.
• Subjects that are skeletally immature.
• Advanced Osteoarthritis; Kellgren Lawrence ≥ 2
• Fracture of the lower extremities within 6 months prior to screening.
• Previous surgery on the affected knee within 12 months related to the ACL reconstruction, prior to screening.
• Sensitivity to silicone, polyester, nylon, FD&C Blue No. 2 dye and beeswax.
• Other concomitant disease that would interfere with study outcomes.
• Subject is included in a vulnerable population (child, prisoner, etc.).
• Conditions that tend to limit the patient's ability or willingness to restrict activities, follow directions, or perform online subject assessments during the healing period.
• Subject is requesting or receiving Worker's compensation related to the knee injury.